Downloads: 0 | Views: 83

Research Paper | Medicine | India | Volume 11 Issue 12, December 2022

Apollo Telehealth's Comprehensive Analysis on the Impact of Telemedicine in the Management of Covid Vaccination Adverse Effects

Dr. Md. Mubasheer Ali | Prashant Janjal | Dr. Akhila Kosuru | Dr. Ayesha Nazneen

Abstract: The COVID-19 pandemic has compelled scientists across the globe to introspect and accelerate research to search for solutions for treatments and vaccines to stop SARS-CoV-2 spread. Studies that have been published, primarily concerning SARS-CoV and to a lesser extent on MERS, have provided guidance on immunisation tactics for this novel coronavirus. (1) . This is based on the argument that severe acute respiratory syndrome virus 2 shares roughly 78 percent genetic similarity with SARS-COV and employs the same receptor namely human Angiotensin Converter Enzyme 2. WHO classified the illness to be pandemic and although research work on COVID vaccines began as soon as the novel coronavirus outbreak started out in China and subsequently to the rest of the world, a reliable and safe vaccine for COVID 19 could not be created until September 2020. In order to stimulate the generation of a cellular and humoral immune response intended to protect the recipient against a specific disease, vaccines primarily mimic a natural illness. The bulk of the known side effects, such as headaches, discomfort, swelling and redness at injection site, muscle aches, fever, and exhaustion, etc., are minimal in terms of severity., (2) . Another widespread concern is people's resistance to receiving safe and advised immunizations, commonly referred to as "vaccine hesitancy." This in-depth analytical review study sought to analyse and assess the benefits of telemedicine in controlling mild to moderate AEFI and describing their detrimental ramifications. These findings could give the general public a better grasp of how mild and moderate side effects from the COVID-19 immunization actually manifest in the real world and how easily they can be managed with telemedicine.

Keywords: post COVID vaccination adverse effects, covaxin, covishield, telemedicine

Edition: Volume 11 Issue 12, December 2022,

Pages: 161 - 167